Territory Stories

NT trends in ecstasy and related drug markets 2011 : findings from the Ecstasy and Related Drugs Reporting System (EDRS)

Details:

Title

NT trends in ecstasy and related drug markets 2011 : findings from the Ecstasy and Related Drugs Reporting System (EDRS)

Collection

NT trends in ecstasy and related drug markets; Reports; PublicationNT

Date

2011

Description

Made available via the Publications (Legal Deposit) Act 2004 (NT).

Notes

Date:2011; Australian drug trends series No. 80

Language

English

Subject

Drug abuse surveys -- Northern Territory -- Periodicals; Ecstasy (Drug) -- Northern Territory -- Periodicals; Drug abuse -- Northern Territory -- Periodicals

Publisher name

National Drug and Alcohol Research Centre, University of New South Wales

Place of publication

Sydney (N.S.W)

ISBN

9780733430206

Copyright owner

Check within Publication or with content Publisher.

Parent handle

https://hdl.handle.net/10070/242182

Citation address

https://hdl.handle.net/10070/610318

Page content

79 6.5 Mental health problems and psychological distress Twenty-seven percent of the IDRS sample reported having experienced a mental health problem in the six months prior to interview. As in previous years, depression was the main mental health problem, followed by anxiety (Table 61). Table 61: Proportion of participants self-reporting recent mental health problems, 2007-2011 (%) 2007 N=106 2008 N=103 2009 N=99 2010 N=99 2011 N=98 Depression 17 19 17 23 16 Manic depression 1 4 3 3 6 Anxiety 10 10 10 16 14 Panic 4 1 2 2 2 Paranoia 2 3 0 2 1 Personality Disorder 1 0 2 0 0 Schizophrenia 3 3 6 4 3 Drug-induced psychosis 1 1 0 0 2 Other psychosis* 0 0 0 0 0 * not drug induced Source: IDRS participant interviews Of the group who had experienced a mental health problem, 73% had attended a mental health professional for the reported problem and 90% of these had been prescribed medication. Sixty-three percent of this last group (n=12) had been prescribed an antidepressant, 35% (n=6) were prescribed a benzodiazepine and 23% (n=4) had been prescribed an anti-psychotic. The types of antidepressant and anti-psychotic medications prescribed are listed below in Table 62. Table 62: Types of medication received for mental health problems, 2007-2011 (%) 2007 N=106 2008 N=103 2009 N=99 2010 N=99 2011* N=98 Antidepressant Endep (amitriptyline) 2 1 0 1 3 Avanza (mirtazapine) 4 1 0 2 0 Zoloft (sertraline) 1 3 3 0 2 Efexor (venlafaxine) 1 0 0 0 Other 2 4 3 7 5 Anti-psychotic Flupenthixol (generic) 1 0 0 0 0 Largactil (chlorpromazine) 1 0 0 0 0 Risperdal (risperidone) 2 1 1 1 0 Seroquel (quetiapine) 1 1 0 3 0 Zyprexa (olanzapine) 2 0 1 0 2 Other 1 1 3 2 2 Source: IDRS participant interviews * two respondents did not specify which anti-depressant. The Kessler Psychological Distress Scale (K10) again formed part of the IDRS interview survey. The K10 is a questionnaire designed to measure the level of distress associated